Rapid Immunoassay for SARS-CoV-2, Influenza Type A and Type B Antigens (25 Tests)

The LifeSign 33225 Status COVID-19/Flu A&B Rapid Immunoassay is a diagnostic kit designed for the simultaneous direct detection and differential diagnosis of SARS-CoV-2, Influenza Type A, and Type B antigens. This 25-test kit includes test devices, extraction reagent capsules, sterile swabs, positive and negative control swabs, as well as package inserts and quick reference instructions.

This rapid immunoassay has received FDA Emergency Use Authorization (EUA) and provides visual results in just 15 minutes. The kit utilizes flocked nasopharyngeal swabs for superior specimen collection and patient comfort.

Key performance characteristics of the LifeSign 33225 Status COVID-19/Flu A&B Rapid Immunoassay include:

COVID-19: - Anterior nasal swab specimen: Sensitivity 93.8%, Specificity 100% - Nasopharyngeal swab specimen: Sensitivity 93.1%, Specificity 100%

Influenza A: - Sensitivity 91.4%, Specificity 95.7%

Influenza B: - Sensitivity 87.6%, Specificity 95.9%

The kit contents include: - 25 Status COVID-19/Flu A&B test devices - 25 Extraction Reagent capsules - 25 Sterile Swabs - 1 Positive Control Swab - 1 Negative Control Swab - 1 Package Insert/Instructions for use - 1 Quick Reference Instructions

This comprehensive diagnostic solution allows for the rapid and accurate detection and differentiation of SARS-CoV-2, Influenza Type A, and Influenza Type B infections, aiding in the effective management and treatment of patients.

product information: